XGN Exagen Inc.
$7.03▲ +0.86%
Healthcare
Other
After hours
$7.04▲ +0.14%
Sep 11, 7:34 PM ET
Volume 476.5K
Avg Volume (10D) 211.5K
Key Metrics & Fundamentals
Market Cap
$170.30M
P/E Ratio
–
Div Yield
–%
52W Range
2.59 - 12.23
% vs 50 MA
17.45%
% vs 200 MA
47.57%
RSI-14
52.5
MACD Histogram
-0.1500
Beta (1Y vs SPY)
2.31
Free Cash Flow
$3.45M
Gross Rev
$19.94M
Gross Profit
$12.22M
EBITDA
-$941,000
COGS
$7.72M
Operating Exp
$13.94M
Operating Income
-$1.72M
EBIT
-$1.72M
Pretax Income
-$3.20M
Net Income
-$3.20M
EPS (Diluted)
-0.13
Price & Volume History
Loading chart…
Recent News
Exagen (XGN) Q2 2026 Earnings Call Transcript
Motley Fool · Aug 11, 2026 5:31 PM
Exagen (XGN) Stock Gets Fair Value Boost As Analysts Weigh Growth And Execution
Simply Wall St. · Aug 6, 2026 4:32 AM
B. Riley Adjusts Price Target on Exagen to $12 From $8, Maintains Buy Rating
MT Newswires · Aug 5, 2026 12:36 PM
Exagen Inc. Q2 2026 Earnings Call Summary
Moby · Aug 4, 2026 9:23 PM
Exagen Inc (XGN) (Q2 2026) Earnings Call Highlights: Record Revenue and Path to Profitability
GuruFocus.com · Aug 4, 2026 9:03 PM
Exagen Q2 Earnings Call Highlights
MarketBeat · Aug 4, 2026 7:04 PM
Exagen Reports Record Second-Quarter 2026 Revenue and Raises Full-Year Guidance
InvestorsHub · Aug 4, 2026 3:28 PM
Exagen Inc. (XGN) Reports Q2 Loss, Beats Revenue Estimates
Zacks · Aug 4, 2026 1:20 PM
Exagen Inc. Reports Second Quarter 2026 Financial Results
GlobeNewswire · Aug 4, 2026 12:00 PM
Exagen Inc. to Participate in Upcoming Investor Conference
GlobeNewswire · Jul 28, 2026 1:00 PM
Financial Overview - Income Statement
Quarterly
Jun 2026
See XGN's money flow as a full page
Social Sentiment
No Reddit posts found for XGN.
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.